Remote Patient Monitoring Market by Product ( ) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User

Description

List of Tables

Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User-Global Forecast to 2031

The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.

Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.

Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.

Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.

Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.

An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.

The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).

Scope of the Report:

Remote Patient Monitoring Market Assessment-by Product

Monitoring Devices
- Monitoring Devices, by Functionality
Blood Glucose Monitoring Devices
Cardiac Monitoring Devices
Neurological Monitoring Devices
Respiratory Monitoring Devices
Multiparameter Monitoring Devices
Blood Pressure Monitoring Devices
Fetal and Neonatal Monitoring Devices
Weight Monitoring Devices
Other Monitoring Devices

Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.

Monitoring Devices, by Type

Wearable Monitoring Devices
Portable Monitoring Devices
Bench-top Monitoring Devices
Software
Services

Remote Patient Monitoring Market Assessment-by Application

Diabetes
Cardiovascular Diseases
Neurological Diseases
Respiratory Diseases
Oncology
Other Applications

Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.

Remote Patient Monitoring Market Assessment-by End User

Home-care Settings
Hospitals
Long-term Care Facilities
Other End Users

Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations

Remote Patient Monitoring Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Product Code: MRHC - 104658

1. Introduction

1.1. Market Definition And Scope
1.2. Market Ecosystem
1.3. Currency And Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection And Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research / Interviews With Key Opinion Leaders of The Industry
2.3. Market Sizing And Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions For The Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Factors Affecting Market Growth
- 4.2.1. Impact Analysis of Market Dynamics
- 4.2.2. Factor Analysis
4.3. Remote Patient Monitoring Market: Regulatory Analysis
- 4.3.1. Overview
- 4.3.2. North America
  - 4.3.2.1. U.S.
  - 4.3.2.2. Canada
- 4.3.3. Europe
- 4.3.4. Asia-Pacific
  - 4.3.4.1. China
  - 4.3.4.2. Japan
  - 4.3.4.3. India
- 4.3.5. Latin America
- 4.3.6. Middle East
4.4. Pricing Analysis
4.5. Industry Trends
- 4.5.1. Shift From Physician-Driven to Consumer-Driven Healthcare
- 4.5.2. Integration of Artificial Intelligence With Remote Patient Monitoring Technologies
4.6. Porter's Five Forces Analysis
- 4.6.1. Bargaining Power of Buyers
- 4.6.2. Bargaining Power of Suppliers
- 4.6.3. Threat of Substitutes
- 4.6.4. Threat of New Entrants
- 4.6.5. Degree of Competition

5. Remote Patient Monitoring Market Assessment- by Product

5.1. Overview
5.2. Monitoring Devices
- 5.2.1. Monitoring Devices, by Functionality
  - 5.2.1.1. Blood Glucose Monitoring Devices
  - 5.2.1.2. Cardiac Monitoring Devices
  - 5.2.1.3. Neurological Monitoring Devices
  - 5.2.1.4. Respiratory Monitoring Devices
  - 5.2.1.5. Multiparameter Monitoring Devices
  - 5.2.1.6. Blood Pressure Monitoring Devices
  - 5.2.1.7. Fetal And Neonatal Monitoring Devices
  - 5.2.1.8. Weight Monitoring Devices
  - 5.2.1.9. Other Monitoring Devices
- 5.2.2. Monitoring Devices, by Type
  - 5.2.2.1. Wearable Monitoring Devices
  - 5.2.2.2. Portable Monitoring Devices
  - 5.2.2.3. Bench-Top Monitoring Devices
5.3. Software
5.4. Services

6. Remote Patient Monitoring Market Assessment-by Application

6.1. Overview
6.2. Diabetes
6.3. Cardiovascular Diseases
6.4. Neurological Disorders
6.5. Respiratory Diseases
6.6. Oncology
6.7. Other Applications

7. Remote Patient Monitoring Market Assessment-by End User

7.1. Overview
7.2. Home-Care Settings
7.3. Long-Term Care Facilities
7.4. Hospitals
7.5. Other End Users

8. Remote Patient Monitoring Market Assessment-by Geography

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
8.3. Europe
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Europe
8.4. Asia-Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies

10. Company Profiles

10.1. Medtronic plc
10.2. Koninklijke Philips N.V.
10.3. Omron Corporation
10.4. Boston Scientific Corporation
10.5. Abbott Laboratories
10.6. Siemens Healthineers AG
10.7. Ge Healthcare Technologies, Inc.
10.8. F. Hoffmann-La Roche AG
10.9. Baxter International Inc.
10.10. Oracle Corporation
10.11. Dexcom, Inc.
10.12. VitalConnect, Inc.
10.13. Other Companies

11. Appendix

11.1. Available Customization
11.2. Related Reports